Overview

Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder

Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
A prospective, single arm, multicenter, Phase II-Trial to assess safety and efficacy of preoperative Radiation therapy before radical CystEctomy combined with ImmunoTherapy in locally advanced urothelial carcinoma of the bladder
Phase:
Phase 2
Details
Lead Sponsor:
Technische Universität München
Collaborator:
Bristol-Myers Squibb
Treatments:
Nivolumab